AAHIVM Encouraged by TMC125 Approval

New HIV Medication Could Offer More Options for Treatment-Experienced Patients WASHINGTON, Feb. 4 /PRNewswire/ -- The American Academy of HIV Medicine (AAHIVM), a national organization of HIV-treating physicians, nurse practitioners and physician assistants, pra...

FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125

- The Prescription Drug User Fee Act (PDUFA) user fee goal date will be January 18, 2008 - YARDLEY, Pa., Sept. 20 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. today announced that the New Drug Application (NDA) for TMC125 (etravirine), an investigational non-nucleosid...

FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125

- The Prescription Drug User Fee Act (PDUFA) user fee goal date will be January 18, 2008 - YARDLEY, Pa., Sept. 20 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. today announced that the New Drug Application (NDA) for TMC125 (etravirine), an investigational non-nucleosid...

Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE

...cebo group). At week 24, 170 (56%) patients in the tmc125 group and 119 (39%) patients in the placebo group ...ents, including neuropsychiatric events, seen with tmc125 were generally comparable with placebo, with the exception of rash (61 [20%] patients on tmc125 vs 30 [10%] on placebo) and diarrhea (36 [12%] pat...

New Drugs Show Promise in Fighting Drug-Resistant HIV

... powerful agents to fight the disease to date, are tmc125 (etravirine) and TMC114 (darunavir, also known as ...is the pivotal registration and efficacy trial for tmc125 (it is in a class of HIV drugs called non-nucleosi...found that at the 24th week, patients who received tmc125 in combination with TMC114 achieved superior virol...

TMC125 in Medical Technology

New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV

...o drugs, amongst the most powerful agents to fight the disease to date, are tmc125 (etravirine) and TMC114 (darunavir, also known as Prezista), both made by T...nd placebo controlled -- is the pivotal registration and efficacy trial for tmc125 (it is in a class of HIV drugs called non-nucleoside reverse transcriptase ...

TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials

...lished in the July 7, 2007, issue of The Lancet. tmc125 is the first NNRTI to show significant antiviral a...plication. DUET-1 and DUET-2 examined the use of tmc125 in combination with other anti-retroviral medicati...were randomized and treated in DUET-1 - 304 in the tmc125 plus background regimen (BR) group and 308 in the ...